Schizotypal traits and their relationship to reading abilities in healthy adults

2024-12-1

Assessment of body Schema distortions in early-onset schizophrenia

2024-12-1

Abnormal hedonic process in patients with stable schizophrenia: Relationships to negative symptoms and social functioning

2024-12-1

Cognitive complaint inversely associated to UHR transition

2024-12-1

Training individuals with schizophrenia to gain volitional control of the theory of mind network with real-time fMRI: A pilot study

2024-9-7

Association of obesity to reaction time and visual memory in schizophrenia

2024-9-1

Longitudinal course of core cognitive domains in first-episode acute and transient psychotic disorders compared with schizophrenia

2024-9-1

Exploring current smartphone-based cognitive assessments in schizophrenia and bipolar disorder

2024-9-1

Anticholinergic load: A commonly neglected and preventable risk to cognition during schizophrenia treatment?

2024-9-1

Neuroinflammation and kynurenines in schizophrenia: Impact on cognition depending on cognitive functioning and modulatory properties in relation to cognitive remediation and aerobic exercise

2024-8-29

Ecological virtual reality-based cognitive remediation among inpatients with schizophrenia: A pilot study

2024-8-28

Fixational eye movements and their associated evoked potentials during natural vision are altered in schizophrenia

2024-8-15

Ten years of schizophrenia research cognition

2024-8-1

Relationship of cognitive measures to mRNA levels in lymphocytes from patients with schizophrenia and controls

2024-6-28

Effect of prior beliefs and cognitive deficits on learning in first-episode schizophrenia patients

2024-6-17

The altered volume of striatum: A neuroimaging marker of treatment in first-episode and drug-naïve schizophrenia

2024-6-1

Montreal Cognitive Assessment (MoCA) as a screening tool for cognitive impairment in early stages of psychosis

2024-6-1

Association between the HHEX polymorphism and delayed memory in first-episode schizophrenic patients

2024-6-1

Does cannabis affect cognitive functioning in patients with schizophrenia?

2024-6-1

Face and emotion recognition in individuals diagnosed with schizophrenia, ultra-high risk for psychosis, unaffected siblings, and healthy controls in a sample from Turkey

2024-6-1

Modulation of hemispheric asymmetry in executive control of attention in schizophrenia with atypical antipsychotic treatment: Potential benefits of olanzapine

2024-6-1

Identity recognition from faces and bodies in schizophrenia spectrum disorders

2024-6-1

Overshadowing and salience attribution in relation to cannabis use

2024-5-11

Decision-making under risk and its correlates in schizophrenia

2024-5-9

Social cognition among clinical subtypes of schizophrenia

2024-4-24

Efficacy of cognitive training on cognition, symptoms and functioning: Impact of motivation and attendance

2024-4-20

PsyCog: A computerised mini battery for assessing cognition in psychosis

2024-3-28

Using virtual reality to improve verbal episodic memory in schizophrenia: A proof-of-concept trial

2024-3-7

Associative learning and facial expression recognition in schizophrenic patients: Effects of social presence

2024-3-1

On the specificity of figurative language comprehension impairment in schizophrenia and its relation to cognitive skills but not psychopathological symptoms - Study on metaphor, humor and irony

2024-3-1

Associations between negative and positive automatic thoughts and clinical variables in patients with schizophrenia

2024-3-1

The Category Fluency Test components and their association with cognition and symptoms in adolescents with schizophrenia

2024-3-1

Range adaptation in schizophrenia: A one-year longitudinal study

2024-3-1

Letter to the editor: “Associative learning and facial expression recognition in schizophrenic patients: Effects of social presence” and “Does cannabis affect cognitive functioning in patients with schizophrenia?”

2024-2-21

Relationship between anemia and its correlates and cognitive function in Chinese patients with chronic schizophrenia: A large cross-sectional study

2024-1-15

Augmentation therapy with serotonin1A receptor partial agonists on neurocognitive function in schizophrenia: A systematic review and meta-analysis

2023-12-1

Correlation analysis between insomnia symptoms and language function in patients with schizophrenia

2023-12-1

Intrusive-like memory errors associate with positive schizotypy

2023-12-1

Self-report versus performance based executive functioning in people with psychotic disorders

2023-12-1

On the specificity of figurative language comprehension impairment in schizophrenia and its relation to cognitive skills but not psychopathological symptoms - Study on metaphor, humor and irony

2023-10-24

Neurocognitive function and mortality in patients with schizophrenia spectrum disorders

2023-9-1

Do loneliness and social exclusion breed paranoia? An experience sampling investigation across the psychosis continuum

2023-9-1

Verbal and visual learning ability in patients with treatment-resistant schizophrenia: A 1-year follow-up study

2023-9-1

Differences in social perception in people with schizophrenia and bipolar disorder

2023-9-1

Sustained attention deficits in schizophrenia: Effect of memory load on the Identical Pairs Continuous Performance Test

2023-9-1

Feasibility of six-month outpatient cognitive remediation in schizophrenia: Experience from the randomized controlled integrated social cognition and social skills therapy study

2023-9-1

Social cognition and apathy between two cognitive subtypes of schizophrenia: Are there the same or different profiles?

2023-9-1

Eye movements and the perceptual span in disordered reading: A comparison of schizophrenia and dyslexia

2023-6-27

The role of the insula in cognitive impairment of schizophrenia

2023-6-1

Preface to themed collection: Cognition in China from 2020 to 2022

2023-6-1